Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Eledon Pharmaceuticals (ELDN) Accumulated Depreciation & Amortization (2013 - 2016)

Eledon Pharmaceuticals posted quarterly Accumulated Depreciation & Amortization of $197000.0 for Q4 2016, up 19.39% year-on-year from $165000.0 in Q1 2016, and up 19.39% on a QoQ basis from $165000.0 in Q4 2015.

Eledon Pharmaceuticals (ELDN) has 4 years of Accumulated Depreciation & Amortization data on file, last reported at $197000.0 in Q4 2016.

  • For the quarter ending Q4 2016, Accumulated Depreciation & Amortization rose 19.39% year-over-year to $197000.0; the trailing twelve-month figure through Dec 2016 stood at $197000.0 (up 19.39% YoY), and the FY2016 full-year result was $197000.0, up 19.39% from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2016 stood at $197000.0, up from $165000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $197000.0 in Q4 2016 and bottomed at $43000.0 in Q4 2013.
  • The 4-year median for Accumulated Depreciation & Amortization is $111500.0 (2014), against an average of $115750.0.
  • The widest annual swing landed in 2015, when Accumulated Depreciation & Amortization soared 184.48%; it then advanced 19.39% in 2016.
  • A 4-year view of Accumulated Depreciation & Amortization shows it stood at $43000.0 in 2013, then jumped by 34.88% to $58000.0 in 2014, then surged by 184.48% to $165000.0 in 2015, then rose by 19.39% to $197000.0 in 2016.
  • The last three Accumulated Depreciation & Amortization figures came in at $197000.0 (Q4 2016), $165000.0 (Q4 2015), and $58000.0 (Q4 2014), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Eledon Pharmaceuticals 419.90 Mn 203.87 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2016 197,000.00
Dec 31, 2016 197,000.00
Dec 31, 2015 165,000.00
Dec 31, 2015 165,000.00
Dec 31, 2014 58,000.00
Dec 31, 2014 58,000.00
Dec 31, 2013 43,000.00
Dec 31, 2013 43,000.00